Hagerty, Inc. (HGTY) · Sep 11, 2026 · Share issuance
10.6M-share secondary — $11.95 per share; 10,637,500 shares sold
Hagerty’s selling stockholder completed an upsized 10.6 million-share sale at $11.95. The company gets no operating capital; dilution and supply are the read-through.
The main event was already known before this filing. Hagerty had publicly announced the secondary offering’s pricing on September 9, so the closing itself is largely confirmation rather than a fresh operating update. The new detail is that the underwriters exercised the full 30-day option, taking the transaction to 10,637,500 shares. 〔0〕
| Offering terms | Filing figure |
|---|---|
| Base shares offered | 9,250,000 |
| Additional option shares | 1,387,500 |
| Total shares sold | 10,637,500 |
| Public offering price | $11.95 per share |
| Seller | Hagerty Holding Corp. |
This is a supply event, not a company-funding event. The filing identifies Hagerty Holding Corp. as the selling stockholder and says it agreed to sell the shares, rather than describing a primary issuance of new shares by Hagerty. 〔1〕 That means the strategic picture is unchanged, but the public float receives a much larger block of stock than the base deal alone would have created.
Against expectations, the incremental surprise is modestly negative. The offering and its $11.95 price were already disclosed; the full exercise of the option increases the final share count by 1.3875 million above the base transaction. With no earnings, guidance, or operating disclosure in the filing, there is no fundamental beat to offset the added supply. The net read is therefore a slightly negative capital-markets event, not a change to Hagerty’s business outlook.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!